Home LiteratureArticle Details
PMID: 15830177 Published · ppublish English Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection.

Diabetologia ·Vol. 48 ·No. 5 ·2005-05-00 ·Pages 878-85

Pearson ER, Pruhova S, Tack CJ, Johansen A, Castleden HA, Lumb PJ, Wierzbicki AS, Clark PM, Lebl J, Pedersen O, Ellard S, Hansen T, Hattersley AT

Abstract

Heterozygous mutations in the gene of the transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha) are considered a rare cause of MODY with only 14 mutations reported to date. The description of the phenotype is limited to single families. We investigated the genetics and phenotype of HNF-4alpha mutations in a large European Caucasian collection. HNF-4alpha was sequenced in 48 MODY probands, selected for a phenotype of HNF-1alpha MODY but negative for HNF-1alpha mutations. Clinical characteristics and biochemistry were compared between 54 HNF-4alpha mutation carriers and 32 familial controls from ten newly detected or previously described families. Mutations in HNF-4alpha were found in 14/48 (29%) probands negative for HNF-1alpha mutations. The mutations found included seven novel mutations: S34X, D206Y, E276D, L332P, I314F, L332insCTG and IVS5nt+1G>A. I314F is the first reported de novo HNF-4alpha mutation. The average age of diagnosis was 22.9 years with frequent clinical evidence of sensitivity to sulphonylureas. Beta cell function, but not insulin sensitivity, was reduced in diabetic mutation carriers compared to control subjects (homeostasis model assessment of beta cell function 29% p<0.001 vs controls). HNF-4alpha mutations were associated with lower apolipoprotein A2 (p=0.001), A1 (p=0.04) and total HDL-cholesterol (p=0.02) than in control subjects. However, in contrast to some previous reports, levels of triglycerides and apolipoprotein C3 were normal. HNF-4alpha mutations are common when no HNF-1alpha mutation is found in strictly defined MODY families. The HNF-4alpha clinical phenotype and beta cell dysfunction are similar to HNF-1alpha MODY and are associated with reduced apolipoprotein A2 levels. We suggest that sequencing of HNF-4alpha should be performed in patients with clinical characteristics of HNF-1alpha MODY in whom mutations in HNF-1alpha are not found.

MeSH Terms
Adolescent Adult Amino Acid Substitution Body Mass Index Body Size Child DNA/genetics,isolation & purification DNA-Binding Proteins/genetics Diabetes Mellitus, Type 2/genetics Europe Female Genetic Predisposition to Disease Hepatocyte Nuclear Factor 4 Humans Male Molecular Biology Mutation, Missense Pedigree Phenotype Phosphoproteins/genetics Transcription Factors/genetics
Chemicals
DNA-Binding Proteins HNF4A protein, human Hepatocyte Nuclear Factor 4 Phosphoproteins Transcription Factors DNA
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Pearson E R
Diabetes and Vascular Medicine, Institute of Biomedical and Clinical Science, Peninsula Medical School, Barrack Road, Exeter EX2 5AX, UK. [email protected]
Pruhova S
Tack C J
Johansen A
Castleden H A J
Lumb P J
Wierzbicki A S
Clark P M
Lebl J
Pedersen O
Ellard S
Hansen T
Hattersley A T
References (41)
41 references, click to expand
  1. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20.
    Diabetes. 1995 Jun;44(6):699-704 PMID: 7789636
  2. The genetic abnormality in the beta cell determines the response to an oral glucose load.
    Diabetologia. 2002 Mar;45(3):427-35 PMID: 11914749
  3. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Hum Mutat. 2003 Nov;22(5):353-62 PMID: 14517946
  4. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.
    N Engl J Med. 2001 Sep 27;345(13):971-80 PMID: 11575290
  5. A novel Phe75fsdelT mutation in the hepatocyte nuclear factor-4alpha gene in a Danish pedigree with maturity-onset diabetes of the young.
    J Clin Endocrinol Metab. 1999 Jan;84(1):367-9 PMID: 9920109
  6. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Lancet. 2003 Oct 18;362(9392):1275-81 PMID: 14575972
  7. A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus.
    J Clin Invest. 1998 Feb 1;101(3):521-6 PMID: 9449683
  8. Identification of new mutations in the hepatocyte nuclear factor 4alpha gene among families with early onset Type 2 diabetes mellitus.
    Diabet Med. 1999 Mar;16(3):193-200 PMID: 10227563
  9. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Diabetes. 1997 Nov;46(11):1749-54 PMID: 9356021
  10. Correct homeostasis model assessment (HOMA) evaluation uses the computer program.
    Diabetes Care. 1998 Dec;21(12):2191-2 PMID: 9839117
  11. Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism.
    Diabetes. 1999 Feb;48(2):423-5 PMID: 10334325
  12. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young.
    Hum Mol Genet. 2001 Sep 15;10(19):2089-97 PMID: 11590126
  13. Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP.
    J Biol Chem. 2002 Dec 20;277(51):49761-6 PMID: 12324453
  14. Different genes, different diabetes: lessons from maturity-onset diabetes of the young.
    Ann Med. 2002;34(3):207-16 PMID: 12173691
  15. Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function.
    J Clin Invest. 2002 Sep;110(6):827-33 PMID: 12235114
  16. Large Family With Maturity-Onset Diabetes of the Young and a Novel V121I Mutation in HNF4A.
    Hum Mutat. 2002 Sep;20(3):230-1 PMID: 12203996
  17. Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    J Clin Invest. 1997 Sep 15;100(6):1400-5 PMID: 9294105
  18. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Diabetes. 2001 Feb;50 Suppl 1:S101-7 PMID: 11272165
  19. Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha.
    Diabetologia. 2003 Feb;46(2):291-5 PMID: 12627330
  20. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.
    Mol Cell Biol. 1999 Dec;19(12):8226-39 PMID: 10567548
  21. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families.
    J Clin Endocrinol Metab. 2002 Jun;87(6):2532-9 PMID: 12050210
  22. Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene.
    Diabetes. 2000 Jun;49(6):961-8 PMID: 10866048
  23. Control of pancreas and liver gene expression by HNF transcription factors.
    Science. 2004 Feb 27;303(5662):1378-81 PMID: 14988562
  24. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population.
    Diabetes. 2004 Apr;53(4):1134-40 PMID: 15047632
  25. Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY.
    Diabetes. 1997 Oct;46(10):1652-7 PMID: 9313765
  26. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)
    Nature. 1996 Dec 5;384(6608):458-60 PMID: 8945471
  27. Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients.
    Diabetologia. 2000 Mar;43(3):364-72 PMID: 10768098
  28. Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes.
    Diabetes. 1999 Dec;48(12 ):2475-9 PMID: 10580439
  29. Triple genetic variation in the HNF-4alpha gene is associated with early-onset type 2 diabetes mellitus in a philippino family.
    Metabolism. 2004 Aug;53(8):959-63 PMID: 15281001
  30. beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.
    Diabetes. 2001 Feb;50 Suppl 1:S94-100 PMID: 11272211
  31. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes.
    Diabetes. 2004 Apr;53(4):1141-9 PMID: 15047633
  32. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree.
    Diabetes. 1994 Jan;43(1):40-6 PMID: 8262315
  33. R127W in HNF4alpha is a loss-of-function mutation causing maturity-onset diabetes of the young (MODY) in a UK Caucasian family.
    Diabetologia. 2000 Sep;43(9):1203 PMID: 11043869
  34. A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young.
    Diabetologia. 1997 Jul;40(7):859-62 PMID: 9243109
  35. Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young.
    Diabetes Care. 1993 Sep;16(9):1254-61 PMID: 8404429
  36. Maturity-onset diabetes of the young caused by a balanced translocation where the 20q12 break point results in disruption upstream of the coding region of hepatocyte nuclear factor-4alpha (HNF4A) gene.
    Diabetes. 2002 Jul;51(7):2329-33 PMID: 12086970
  37. A genetic switch in pancreatic beta-cells: implications for differentiation and haploinsufficiency.
    Diabetes. 2002 Aug;51(8):2355-62 PMID: 12145145
  38. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels.
    Diabetes. 2000 May;49(5):832-7 PMID: 10905494
  39. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.
    Diabet Med. 2000 Jul;17(7):543-5 PMID: 10972586
  40. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.
    Mol Cell Biol. 2001 Feb;21(4):1393-403 PMID: 11158324
  41. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
    Diabetologia. 1985 Jul;28(7):412-9 PMID: 3899825
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
0012-186X
Published
2005-05-00
Epub
2005-00-14
Pages
878-85
Language
English
Region
Germany
NLM ID
0006777
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]